{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:55:26Z","timestamp":1781639726010,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007343","name":"Universit\u00e0 degli Studi di Brescia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007343","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00259-026-07794-6","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:47:35Z","timestamp":1772761655000},"page":"4913-4921","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic role of pretreatment [18F]FDG PET\/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4839-9033","authenticated-orcid":false,"given":"Francesco","family":"Dondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide Lorenzo","family":"Bettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8962-5020","authenticated-orcid":false,"given":"Deborah","family":"Cosentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4082-2303","authenticated-orcid":false,"given":"Roberta","family":"Ambrosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3248-6655","authenticated-orcid":false,"given":"Sara","family":"Rodella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0835-0916","authenticated-orcid":false,"given":"Andrea","family":"Abate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7827-0025","authenticated-orcid":false,"given":"Mariangela","family":"Tamburello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1795-7508","authenticated-orcid":false,"given":"Valentina","family":"Cremaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Casole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7635-1179","authenticated-orcid":false,"given":"Guido Alberto Massimo","family":"Tiberio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3294-4121","authenticated-orcid":false,"given":"Sandra","family":"Sigala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6922-1934","authenticated-orcid":false,"given":"Salvatore","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2980-5964","authenticated-orcid":false,"given":"Francesco","family":"Bertagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3956-0043","authenticated-orcid":false,"given":"Alfredo","family":"Berruti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8457-122X","authenticated-orcid":false,"given":"Marta","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"7794_CR1","doi-asserted-by":"publisher","unstructured":"Fassnacht M, Assie G, Baudin E, Eisenhofer G, de la Fouchardiere C, Haak HR, de Krijger R, Porpiglia F, Terzolo M, Berruti A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(11):1476\u20131490. https:\/\/doi.org\/10.1016\/j.annonc.2020.08.2099","DOI":"10.1016\/j.annonc.2020.08.2099"},{"issue":"1","key":"7794_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/EJE-21-0510","volume":"186","author":"YS Elhassan","year":"2021","unstructured":"S-GRAS score for prognostic classification of, Elhassan YS, Altieri B, Berhane S, Cosentini D, Calabrese A, Haissaguerre M, Kastelan D, Fragoso MCBV, Bertherat J, Al Ghuzlan A, Haak H, Boudina M, Canu L, Loli P, Sherlock M, Kimpel O, Lagan\u00e0 M, Sitch AJ, Kroiss M, Arlt W, Terzolo M, Berruti A, Deeks JJ, Lib\u00e9 R, Fassnacht M, Ronchi. Adrenocortical carcinoma: an international, multicenter ENSAT study. CL Eur J Endocrinol. 2021;186(1):25\u201336.","journal-title":"CL Eur J Endocrinol"},{"issue":"10","key":"7794_CR3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S2213-8587(23)00193-6","volume":"11","author":"M Terzolo","year":"2023","unstructured":"Terzolo M, Fassnacht M, Perotti P, Lib\u00e9 R, Kastelan D, Lacroix A, Arlt W, Haak HR, Loli P, Decoudier B, Lasolle H, Quinkler M, Haissaguerre M, Chabre O, Caron P, Stigliano A, Giordano R, Zatelli MC, Bancos I, Fragoso MCBV, Canu L, Luconi M, Puglisi S, Basile V, Reimondo G, Kroiss M, Megerle F, Hahner S, Kimpel O, Dusek T, N\u00f6lting S, Bourdeau I, Chortis V, Ettaieb MH, Cosentini D, Grisanti S, Baudin E, Berchialla P, Bovis F, Sormani MP, Bruzzi P, Beuschlein F, Bertherat J, Berruti A. Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study. Lancet Diabetes Endocrinol. 2023;11(10):720\u201330.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"7794_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1677\/erc.1.01025","volume":"12","author":"A Berruti","year":"2005","unstructured":"Berruti A, Terzolo M, Sperone P, Pia A, Della Casa S, Gross DJ, Carnaghi C, Casali P, Porpiglia F, Mantero F, Reimondo G, Angeli A, Dogliotti L. Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. Endocr Relat Cancer. 2005;12(3):657\u201366.","journal-title":"Endocr Relat Cancer"},{"issue":"12","key":"7794_CR5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1080\/14656566.2022.2106128","volume":"23","author":"A Abate","year":"2022","unstructured":"Advances in adrenocortical, Abate A, Cosentini D, Grisanti S, Rossini E, Lagan\u00e0 M, Tamburello M, Turla A, Sigala S, Berruti AE. Carcinoma pharmacotherapy: what is the current state of the art?Cremaschi V. Opin Pharmacother. 2022;23(12):1413\u201324.","journal-title":"Opin Pharmacother"},{"issue":"4","key":"7794_CR6","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/cancers12040941","volume":"12","author":"M Lagan\u00e0","year":"2020","unstructured":"Lagan\u00e0 M, Grisanti S, Cosentini D, Ferrari VD, Lazzari B, Ambrosini R, Sardini C, Volta AD, Palumbo C, Poliani PL, Terzolo M, Sigala S, Tiberio GAM, Berruti A. Efficacy of the EDP-M scheme plus adjunctive surgery in the management of patients with advanced adrenocortical carcinoma: the Brescia experience. Cancers (Basel). 2020;12(4):941. https:\/\/doi.org\/10.3390\/cancers12040941. PMID: 32290298; PMCID: PMC7226395.","journal-title":"Cancers (Basel)"},{"key":"7794_CR7","doi-asserted-by":"publisher","unstructured":"Vesselle H, Salskov A, Turcotte E, Wiens L, Schmidt R, Jordan CD, Valli\u00e8res E, Wood DE. Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index. J Thorac Oncol. 2008;3(9):971\u20138. https:\/\/doi.org\/10.1097\/JTO.0b013e31818307a7","DOI":"10.1097\/JTO.0b013e31818307a7"},{"issue":"1","key":"7794_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5603\/NMR.a2022.0012","volume":"25","author":"P Bellini","year":"2022","unstructured":"Bellini P, Albano D, Dondi F, Bertagna F, Giubbini R Different glucose metabolism behavior relating to histotypes in synchronous breast cancers evaluated by [18F]FDG PET-CT. Nucl Med Rev Cent East Eur. 2022;25(1):64\u20135. . https:\/\/doi.org\/10.5603\/NMR.a2022.0012.","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"7794_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.clinimag.2022.11.014","volume":"94","author":"F Dondi","year":"2023","unstructured":"Dondi F, Albano D, Bellini P, Cerudelli E, Treglia G, Bertagna F. Prognostic role of baseline 18F-FDG pet\/CT in stage I and stage Ii non-small cell lung cancer. Clin Imaging. 2023;94:71\u20138. Epub 2022 Dec 2. PMID: 36495848.","journal-title":"Clin Imaging"},{"issue":"11","key":"7794_CR10","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1002\/hed.27145","volume":"44","author":"F Dondi","year":"2022","unstructured":"Dondi F, Pasinetti N, Guerini A, Piazza C, Mattavelli D, Bossi P, Berruti A, Ravanelli M, Farina D, Albano D, Treglia G, Bertagna F. Prognostic role of baseline 18 F-FDG pet\/CT in squamous cell carcinoma of the paranasal sinuses. Head Neck. 2022;44(11):2395\u2013406. https:\/\/doi.org\/10.1002\/hed.27145. Epub 2022 Jul 12. PMID: 35818852.","journal-title":"Head Neck"},{"issue":"2","key":"7794_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.amjsurg.2022.08.020","volume":"225","author":"SM Wrenn","year":"2023","unstructured":"Wrenn SM, Moore AL, Shah HJ, Barletta JA, Vaidya A, Kilbridge KL, Doherty GM, Jacene HA, Nehs MA. Higher SUVmax on FDG-PET is associated with shorter survival in adrenocortical carcinoma. Am J Surg. 2023;225(2):309\u201314. Epub 2022 Sep 8. PMID: 36137821.","journal-title":"Am J Surg"},{"issue":"Suppl 3","key":"7794_CR12","doi-asserted-by":"publisher","first-page":"S714","DOI":"10.1245\/s10434-015-4813-8","volume":"22","author":"K Satoh","year":"2015","unstructured":"Satoh K, Patel D, Dieckmann W, Nilubol N, Kebebew E. Whole body metabolic tumor volume and total lesion Glycolysis predict survival in patients with adrenocortical carcinoma. Ann Surg Oncol. 2015;22(Suppl 3):S714\u201320. https:\/\/doi.org\/10.1245\/s10434-015-4813-8. Epub 2015 Aug 18. PMID: 26282908.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"7794_CR13","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1007\/s12020-024-03695-6","volume":"84","author":"W Schl\u00f6telburg","year":"2024","unstructured":"Schl\u00f6telburg W, Hartrampf PE, Kosmala A, Fuss CT, Serfling SE, Buck AK, Schirbel A, Kircher S, Hahner S, Werner RA, Fassnacht M. Prognostic role of quantitative [18F]FDG PET\/CT parameters in adrenocortical carcinoma. Endocrine. 2024;84(3):1172\u201381. https:\/\/doi.org\/10.1007\/s12020-024-03695-6. Epub 2024 Feb 21. PMID: 38381353; PMCID: PMC11208261.","journal-title":"Endocrine"},{"issue":"1","key":"7794_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00268-012-1802-y","volume":"37","author":"L de la Tessonnier","year":"2013","unstructured":"Tessonnier L, Ansquer C, Bournaud C, Sebag F, Miralli\u00e9 E, Lifante JC, Palazzo FF, Morange I, Drui D, de la Foucard\u00e8re C, Mancini J, Ta\u00efeb D (18)F-FDG uptake at initial staging of the adrenocortical cancers: a diagnostic tool but not of prognostic value. World J Surg. 2013;37(1):107\u201312. . https:\/\/doi.org\/10.1007\/s00268-012-1802-y.","journal-title":"World J Surg"},{"key":"7794_CR15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Weber WA, Stroobants S, Delbeke D, Donohoe KJ, Holbrook S, Graham MM, Testanera G, Hoekstra OS, Zijlstra J, Visser E, Hoekstra CJ, Pruim J, Willemsen A, Arends B, Kotzerke J, Bockisch A, Beyer T, Chiti A, Krause BJ. European association of nuclear medicine (EANM). FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328\u201354. https:\/\/doi.org\/10.1007\/s00259-014-2961-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"23","key":"7794_CR16","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","volume":"366","author":"M Fassnacht","year":"2012","unstructured":"Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Schade-Brittinger C, Lacroix A, Jarzab B, Sorbye H, Torpy DJ, Stepan V, Schteingart DE, Arlt W, Kroiss M, Leboulleux S, Sperone P, Sundin A, Hermsen I, Hahner S, Willenberg HS, Tabarin A, Quinkler M, de la Fouchardi\u00e8re C, Schlumberger M, Mantero F, Weismann D, Beuschlein F, Gelderblom H, Wilmink H, Sender M, Edgerly M, Kenn W, Fojo T, M\u00fcller HH, Skogseid B, FIRM-ACT Study Group. Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med. 2012;366(23):2189\u201397. https:\/\/doi.org\/10.1056\/NEJMoa1200966. Epub 2012 May 2. PMID: 22551107.","journal-title":"N Engl J Med"},{"issue":"6","key":"7794_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12672-011-0091-5","volume":"2","author":"D Deandreis","year":"2011","unstructured":"Deandreis D, Leboulleux S, Caramella C, Schlumberger M, Baudin E. FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma. Horm Cancer. 2011;2(6):354\u201362. https:\/\/doi.org\/10.1007\/s12672-011-0091-5. PMID: 22076881; PMCID: PMC10358045.","journal-title":"Horm Cancer"},{"issue":"3","key":"7794_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/ijnm.ijnm_4_22","volume":"37","author":"VS Krishnaraju","year":"2022","unstructured":"Krishnaraju VS, Kumar R, Subramanian K, Mittal BR, Singh H, Chatterjee D, Walia R. Fluoro-2-deoxyglucose-positron emission tomography\/computed tomography in the diagnosis and management of adrenocortical carcinoma: a 10-year experience from a tertiary care Institute. Indian J Nucl Med. 2022;37(3):227\u201335.","journal-title":"Indian J Nucl Med"},{"issue":"4","key":"7794_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/RLU.0000000000005083","volume":"49","author":"S Hahner","year":"2024","unstructured":"Hahner S, Higuchi T, Serfling SE, Samnick S, Fuss CT, Heinze B, Buck AK, Schirbel A, Fassnacht M, Werner RA. Exploring theranostic avenues in adrenocortical carcinoma using chemokine receptor and Prostate-Specific membrane Antigen-Directed PET\/CT. Clin Nucl Med. 2024;49(4):369\u201370. Epub 2024 Feb 9. PMID: 38350087.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"7794_CR20","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1210\/jc.2005-1540","volume":"91","author":"S Leboulleux","year":"2006","unstructured":"Leboulleux S, Dromain C, Bonniaud G, Aup\u00e9rin A, Caillou B, Lumbroso J, Sigal R, Baudin E, Schlumberger M. Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography. J Clin Endocrinol Metab. 2006;91(3):920\u20135. https:\/\/doi.org\/10.1210\/jc.2005-1540. Epub 2005 Dec 20. PMID: 16368753.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"7794_CR21","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1007\/s00259-014-2834-3","volume":"41","author":"S Takeuchi Jr","year":"2014","unstructured":"Takeuchi S, Balachandran A, Habra MA, Phan AT, Bassett RL Jr, Macapinlac HA, Chuang HH Impact of \u00b9\u2078F-FDG PET\/CT on the management of adrenocortical carcinoma: analysis of 106 patients. Eur J Nucl Med Mol Imaging. 2014;41(11):2066\u201373. . https:\/\/doi.org\/10.1007\/s00259-014-2834-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"7794_CR22","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2967\/jnumed.116.186353","volume":"58","author":"MA Lodge","year":"2017","unstructured":"Lodge MA. Repeatability of SUV in oncologic 18F-FDG PET. J Nucl Med. 2017;58(4):523\u201332. https:\/\/doi.org\/10.2967\/jnumed.116.186353. Epub 2017 Feb 23. PMID: 28232605; PMCID: PMC5373499.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07794-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07794-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07794-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:27:33Z","timestamp":1781638053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07794-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["7794"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07794-6","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University of Brescia. Patients were enrolled and adhered to the ENS@T registry (European Network for the Study of Adrenal Tumors), in compliance with registry guidelines and under the oversight of the registry\u2019s coordinating center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figure 3.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}